Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins

Clinical and Experimental Dermatology

Volumn 28, Issue 3, 2003, Pages 269-271

  Tan, A ^a,b   Tan, H H ^a   Lee, C C ^a   Ng, S K ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL SKIN CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIPROTOZOAL AGENT; ANTIRETROVIRUS AGENT; CARBAMAZEPINE; CHINESE DRUG; CORTICOSTEROID; COTRIMOXAZOLE; EFAVIRENZ; FOLINIC ACID; IMMUNOGLOBULIN; LAMIVUDINE; PYRIMETHAMINE; SULFADIAZINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; CHINESE MEDICINE; CYTOMEGALOVIRUS INFECTION; DERMATITIS; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; MALE; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETINITIS; SEIZURE; SIDE EFFECT; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS; TOXOPLASMOSIS; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED;

EID: 0038454852     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01255.x     Document Type: Article

References (7)

1. Revuz J, Penso D, Roujeau J-C et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987; 123: 1160-5.
2. Khoo AKM. Foo CL. Toxic epidermal necrolysis in a burns centre: a 6-year review. Burns 1996; 22: 275-8.
3. Rzany B, Mockenhaupt M, Stocker U, Hamouda O, Schopf E. Incidence of Stevens-Johnson Syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany. Arch Dermatol 1993; 129: 1059.
4. Saiag P, Caumes E, Chosidow O, Revuz J, Roujeau JC. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients with the human immunodeficiency virus. J Am Acad Dermatol 1992; 40: 567-74.
5. Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490-3.
6. Sanwo M, Nwadiuko R, Beall G. Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS. J Allergy Clin Immunol 1996; 98: 1112-5.
7. Phan TG, Wong RC, Crotty K, Adelstein S. Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin. Australas J Dermatol 1999; 40: 153-7.